血栓溶解剂(Thrombolytics)：并用Clopidogrel、rt-PA 和肝素于最近发生心肌梗塞病人的安全性评估结果显 示其出血的发生率和并用ASA 并用rt-PA 和肝素近 似。
基于16个网页-相关网页
结论——在一些列nihss评分中的相应改变可以作为经静脉注射血栓溶解剂后一个简单的血管状态的临床指示器。
Conclusions - Relative changes in serial NIHSS scores can serve as a simple clinical indicator of arterial status after intravenous thrombolysis.
背景——经静脉注射血栓溶解剂后早期恢复可以在中风中发现，然而，有关评价临床治疗改善血管状态的益处的量表还未建立。
Background - Early recovery after intravenous thrombolysis can be observed in stroke; however, the utility of measuring clinical improvement to assess artery status has not been established.
一个好的溶纤剂能够溶解陈旧或新鲜的血栓，再栓塞率低。
A good thrombolytic drug could dissolve not only old thrombus but also new thrombus, and lower rate of thrombus formed again.
应用推荐